Crism Therapeutics Corporation AIM:CRTX
- Incorporated
- British Virgin Islands
- Reports in
- USD
Where the figures come from
How we read Read straight from the annual reports
Share price and financials
9.3c at close on 5 Oct 2026 · 4 reported years, 2022–2025
Years in viewFY2022 – FY2026
5 Oct 20269.3c−96.6% since 31 Dec 2021
9.3c
| Line | FY202212/22 | FY202312/23 | FY202412/24 | FY202512/25 | FY2026unreported |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Gross profit | — | ||||
| Operating profit | |||||
| Exceptional items | — | — | |||
| Net finance cost | |||||
| Profit before tax | |||||
| Tax charge | |||||
| Profit for the year | |||||
| EBITDA | — | — | |||
| Basic EPS | |||||
| Diluted EPS | |||||
| Dividend per share |
USD millions, negatives in brackets. Per-share lines in cents, share counts in millions. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated. The share price above is drawn to the same columns: each close sits over the financial year it fell in.
Revenue
3 years, at a glance
C000337-AR-2025-website
Filings
0 annual reports read
Sources: Company website (3)
No filings have been read for this company yet.